Search
for
Sort by
Research 361–390 of 998
- The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Short- and mid-term outcomes of multisystem inflammatory syndrome in children: a longitudinal prospective single-center cohort study
- Safety and efficacy of oral administrated cepharanthine in non-hospitalized, asymptomatic or mild COVID-19 patients: a Double-blind, randomized, placebo-controlled trial
- Extraordinary claims without extraordinary evidence: controversy on anti‐androgen therapy for COVID‐19
- Reply to: “Comment on ‘Androgenetic alopecia present in the majority of patients hospitalized with COVID-19’”
- Dermoscopy-assisted prevalence of hair loss after COVID-19 vaccination among an Egyptian population: a cross-sectional study
- Rational evaluation of patients with COVID-19-related hair loss
- Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2
- A narrative review of SARS-CoV-2 variants and long COVID
- Hair disorders associated with post-COVID-19 infection in females: a cross-sectional study
- 219 Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid
- Ayurvedic Rasayan formulations having potential for managing post COVID ailments- a narrative review
- Change in dermatology practice during crisis and normalization periods after the COVID-19 pandemic and potential problems awaiting us
- Pathological sequelae of long-haul COVID
- Insights into disparities observed with COVID‐19
- From causes of aging to death from COVID-19
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- The COVID-19 Sequelae: A Cross-Sectional Evaluation of Post-recovery Symptoms and the Need for Rehabilitation of COVID-19 Survivors
- Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential
- COVID‐19 and cutaneous manifestations: A review of the published literature
- Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Sex steroid hormones are associated with mortality in COVID-19 patients
- Analysis of dermatology-related search engine trends during the COVID-19 pandemic: Implications for patient demand for outpatient services and telehealth
- Discovery of COVID-19 Inhibitors Targeting the SARS-CoV2 Nsp13 Helicase
- Solanum nigrum L. in COVID-19 and post-COVID complications: a propitious candidate
- Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis
- Caution in the time of rashes and COVID-19